Tag: core

MONTREAL, June 25, 2025 (GLOBE NEWSWIRE) -- Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is proud to announce that it has been named the top company in Corporate Knights’ annual ‘Best 50 Corporate Citizens’ ranking in Canada. This ranking recognizes companies that demonstrate outstanding leadership and commitment to sustainable development. This achievement highlights the importance Boralex places on corporate responsibility, which lies at the core of its business strategy.

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Partnership with leading robotic lawn mower developer marks strategic diversification beyond automotive intelligence sector

DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- CoinBom has officially launched its new AI-Powered Copy Trading System, marking a significant milestone in the platform’s continued commitment to intelligent wealth management and quantitative investment. This system integrates advanced AI algorithms with cyclical trading strategies, offering users a more stable and efficient way to grow their digital asset portfolios.

NEW YORK and NEW ORLEANS, June 24, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against Tempus AI, Inc. (NasdaqGS: TEM), if they purchased the Company’s shares between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.